These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 27893707)

  • 1. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
    Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
    Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis.
    Brooks GD; McLeod L; Alhayyani S; Miller A; Russell PA; Ferlin W; Rose-John S; Ruwanpura S; Jenkins BJ
    Cancer Res; 2016 Feb; 76(4):866-76. PubMed ID: 26744530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer-induced cachexia is Jak2-dependent in mice.
    Gilabert M; Calvo E; Airoldi A; Hamidi T; Moutardier V; Turrini O; Iovanna J
    J Cell Physiol; 2014 Oct; 229(10):1437-43. PubMed ID: 24648112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-11-driven gastric tumourigenesis is independent of trans-signalling.
    Balic JJ; Garbers C; Rose-John S; Yu L; Jenkins BJ
    Cytokine; 2017 Apr; 92():118-123. PubMed ID: 28160627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6/Stat3-driven pulmonary inflammation, but not emphysema, is dependent on interleukin-17A in mice.
    Ruwanpura SM; McLeod L; Brooks GD; Bozinovski S; Vlahos R; Longano A; Bardin PG; Anderson GP; Jenkins BJ
    Respirology; 2014 Apr; 19(3):419-27. PubMed ID: 24506702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
    Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
    Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
    Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
    PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.
    Ruwanpura SM; McLeod L; Miller A; Jones J; Vlahos R; Ramm G; Longano A; Bardin PG; Bozinovski S; Anderson GP; Jenkins BJ
    Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(7):L627-39. PubMed ID: 22268122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
    Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
    J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.
    Miller A; Brooks GD; McLeod L; Ruwanpura S; Jenkins BJ
    Oncogene; 2015 Mar; 34(12):1510-9. PubMed ID: 24727895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model.
    Thiem S; Eissmann MF; Elzer J; Jonas A; Putoczki TL; Poh A; Nguyen P; Preaudet A; Flanagan D; Vincan E; Waring P; Buchert M; Jarnicki A; Ernst M
    Cancer Res; 2016 Apr; 76(8):2277-87. PubMed ID: 26837764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.
    Grabner B; Schramek D; Mueller KM; Moll HP; Svinka J; Hoffmann T; Bauer E; Blaas L; Hruschka N; Zboray K; Stiedl P; Nivarthi H; Bogner E; Gruber W; Mohr T; Zwick RH; Kenner L; Poli V; Aberger F; Stoiber D; Egger G; Esterbauer H; Zuber J; Moriggl R; Eferl R; Győrffy B; Penninger JM; Popper H; Casanova E
    Nat Commun; 2015 Mar; 6():6285. PubMed ID: 25734337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
    Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):975-988. PubMed ID: 38632714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression.
    Makino Y; Hikita H; Kato S; Sugiyama M; Shigekawa M; Sakamoto T; Sasaki Y; Murai K; Sakane S; Kodama T; Sakamori R; Kobayashi S; Eguchi H; Takemura N; Kokudo N; Yokoi H; Mukoyama M; Tatsumi T; Takehara T
    Cell Mol Gastroenterol Hepatol; 2023; 15(1):99-119. PubMed ID: 36210625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
    Guo D; Wang C; Wang Q; Qiao Z; Tang H
    Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.
    Akbay EA; Koyama S; Liu Y; Dries R; Bufe LE; Silkes M; Alam MM; Magee DM; Jones R; Jinushi M; Kulkarni M; Carretero J; Wang X; Warner-Hatten T; Cavanaugh JD; Osa A; Kumanogoh A; Freeman GJ; Awad MM; Christiani DC; Bueno R; Hammerman PS; Dranoff G; Wong KK
    J Thorac Oncol; 2017 Aug; 12(8):1268-1279. PubMed ID: 28483607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis.
    Liu J; Cho SN; Wu SP; Jin N; Moghaddam SJ; Gilbert JL; Wistuba I; DeMayo FJ
    Lung Cancer; 2017 Oct; 112():47-56. PubMed ID: 29191600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
    Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M
    Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
    Chen W; Yuan H; Cao W; Wang T; Chen W; Yu H; Fu Y; Jiang B; Zhou H; Guo H; Zhao X
    Theranostics; 2019; 9(14):3980-3991. PubMed ID: 31281526
    [No Abstract]   [Full Text] [Related]  

  • 20. EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.
    Clay TD; Russell PA; Do H; Sundararajan V; Conron M; Wright GM; Solomon B; Dobrovic A; McLachlan SA; Moore MM
    Med Oncol; 2017 Sep; 34(10):175. PubMed ID: 28879441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.